Issue

Vol. 17 (2025)

Designing a Sulfur Vacancy Redox Disruptor for Photothermoelectric and Cascade-Catalytic-Driven Cuproptosis–Ferroptosis–Apoptosis Therapy

https://doi.org/10.1007/s40820-025-01828-8
Mengshu Xu
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China
Jingwei Liu
Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province and College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin 150025, People’s Republic of China
Lili Feng
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China
Jiahe Hu
Cancer Center, Department of Neurosurgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Zhejiang 310014, People’s Republic of China
Wei Guo
Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province and College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin 150025, People’s Republic of China
Huiming Lin
Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province and College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin 150025, People’s Republic of China
Bin Liu
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China
Yanlin Zhu
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China
Shuyao Li
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China
Elyor Berdimurodov
Department of Physical Chemistry, National University of Uzbekistan, 100034 Tashkent, Uzbekistan
Avez Sharipov
Faculty of Pharmacy, Department of Inorganic, Physical and Colloidal Chemistry, Tashkent Pharmaceutical Institute, 100015 Tashkent, Uzbekistan
Piaoping Yang
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, People’s Republic of China

Corresponding Author: Piaoping Yang

yangpiaoping@hrbeu.edu.cn

Nano-Micro Letters, Vol. 17 (2025), Article Number: 321

Abstract

The therapeutic efficacy of cuproptosis, ferroptosis, and apoptosis is hindered by inadequate intracellular copper and iron levels, hypoxia, and elevated glutathione (GSH) expression in tumor cells. Thermoelectric technology is an emerging frontier in medical therapy that aims to achieve efficient thermal and electrical transport characteristics within a narrow thermal range for biological systems. Here, we systematically constructed biodegradable Cu2MnS3-x-PEG/glucose oxidase (MCPG) with sulfur vacancies (SV) using photothermoelectric catalysis (PTEC), photothermal-enhanced enzyme catalysis, and starvation therapy. This triggers GSH consumption and disrupts intracellular redox homeostasis, leading to immunogenic cell death. Under 1064 nm laser irradiation, MCPG enriched with SV, owing to doping, generates a local temperature gradient that activates PTEC and produces toxic reactive oxygen species (ROS). Hydroxyl radicals and oxygen are generated through peroxide and catalase-like processes. Increased oxygen levels alleviate tumor hypoxia, whereas hydrogen peroxide production from glycometabolism provides sufficient ROS for a cascade catalytic reaction, establishing a self-reinforcing positive mechanism. Density functional theory calculations demonstrated that vacancy defects effectively enhanced enzyme catalytic activity. Multimodal imaging-guided synergistic therapy not only damages tumor cells, but also elicits an antitumor immune response to inhibit tumor metastasis. This study offers novel insights into the cuproptosis/ferroptosis/apoptosis pathways of Cu-based PTEC nanozymes.


Highlights:
1 The glycometabolism and enzyme activity of Cu2MnS3-x-PEG/glucose oxidase (MCPG) achieve a cascade catalytic reaction, continuously replenishing the deficient H2O2 and O2 and inducing adequate reactive oxygen species supply.
2 Density functional theory calculations indicate that Mn doping facilitates the structural reconstruction and evolution of sulfur vacancies (SV) sites, leading to a remarkable increase in the catalytic activity of Cu2MnS3-x.
3 Under 1064 nm laser irradiation, MCPG with abundant SV drives charge carrier diffusion from hotter to cooler regions, thus creating a potential difference and activating the photothermoelectric catalysis.

Keywords

Cuproptosis Enzyme catalysis Immunology Photothermoelectric catalysis Vacancy defects
Xu, Mengshu, Jingwei Liu, Lili Feng, Jiahe Hu, Wei Guo, Huiming Lin, Bin Liu, Yanlin Zhu, Shuyao Li, Elyor Berdimurodov, Avez Sharipov, and Piaoping Yang. 2025. “Designing a Sulfur Vacancy Redox Disruptor for Photothermoelectric and Cascade-Catalytic-Driven Cuproptosis–Ferroptosis–Apoptosis Therapy”. Nano-Micro Letters 17 (July):321. https://doi.org/10.1007/s40820-025-01828-8.
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. L. Yang, Z. Zhao, B. Tian, M. Yang, Y. Dong et al., A singular plasmonic-thermoelectric hollow nanostructure inducing apoptosis and cuproptosis for catalytic cancer therapy. Nat. Commun. 15(1), 7499 (2024). https://doi.org/10.1038/s41467-024-51772-1
  2. H. Zhou, H. Inoue, M. Ujita, T. Yamada, Advancement of electrochemical thermoelectric conversion with molecular technology. Angew. Chem. Int. Ed. 62(2), e202213449 (2023). https://doi.org/10.1002/anie.202213449
  3. X. Ji, Z. Tang, H. Liu, Y. Kang, L. Chen et al., Nanoheterojunction-mediated thermoelectric strategy for cancer surgical adjuvant treatment and β-elemene combination therapy. Adv. Mater. 35(8), 2207391 (2023). https://doi.org/10.1002/adma.202207391
  4. L.E. Bell, Cooling, heating, generating power, and recovering waste heat with thermoelectric systems. Science 321(5895), 1457–1461 (2008). https://doi.org/10.1126/science.1158899
  5. Y. He, S. Li, R. Chen, X. Liu, G.O. Odunmbaku et al., Ion-electron coupling enables ionic thermoelectric material with new operation mode and high energy density. Nano-Micro Lett. 15(1), 101 (2023). https://doi.org/10.1007/s40820-023-01077-7
  6. X.-L. Shi, J. Zou, Z.-G. Chen, Advanced thermoelectric design: from materials and structures to devices. Chem. Rev. 120(15), 7399–7515 (2020). https://doi.org/10.1021/acs.chemrev.0c00026
  7. J. Tang, R. Zhu, Y.-H. Pai, Y. Zhao, C. Xu et al., Thermoelectric modulation of neat Ti3C2Tx MXenes by finely regulating the stacking of nanosheets. Nano-Micro Lett. 17(1), 93 (2024). https://doi.org/10.1007/s40820-024-01594-z
  8. X. Yuan, Y. Kang, J. Dong, R. Li, J. Ye et al., Self-triggered thermoelectric nanoheterojunction for cancer catalytic and immunotherapy. Nat. Commun. 14(1), 5140 (2023). https://doi.org/10.1038/s41467-023-40954-y
  9. P. Zang, Y. Du, C. Yu, D. Yang, S. Gai et al., Photothermal-actuated thermoelectric therapy by harnessing Janus-structured Ag–Ag2S nanops with enhanced antitumor efficacy. Chem. Mater. 35(18), 7770–7780 (2023). https://doi.org/10.1021/acs.chemmater.3c01637
  10. A. Zhang, Z. Jiang, S. Zhang, P. Lan, N. Miao et al., Coral-shaped Mn-CuS with hierarchical pores and crystalline defects for high-efficiency H2O2 production via electrocatalytic two-electron reduction. Appl. Catal. B Environ. 331, 122721 (2023). https://doi.org/10.1016/j.apcatb.2023.122721
  11. S. Dong, Y. Dong, Z. Zhao, J. Liu, S. Liu et al., Electron transport chain interference” strategy of amplified mild-photothermal therapy and defect-engineered multi-enzymatic activities for synergistic tumor-personalized suppression. J. Am. Chem. Soc. 145(17), 9488–9507 (2023). https://doi.org/10.1021/jacs.2c09608
  12. L. Liu, J. Wu, L. Wu, M. Ye, X. Liu et al., Phase-selective synthesis of 1T’ MoS2 monolayers and heterophase bilayers. Nat. Mater. 17(12), 1108–1114 (2018). https://doi.org/10.1038/s41563-018-0187-1
  13. Y. Yu, G.-H. Nam, Q. He, X.-J. Wu, K. Zhang et al., High phase-purity 1T’-MoS2- and 1T’-MoSe2-layered crystals. Nat. Chem. 10(6), 638–643 (2018). https://doi.org/10.1038/s41557-018-0035-6
  14. M. Xu, G. Yang, H. Bi, J. Xu, S. Dong et al., An intelligent nanoplatform for imaging-guided photodynamic/photothermal/chemo-therapy based on upconversion nanops and CuS integrated black phosphorus. Chem. Eng. J. 382, 122822 (2020). https://doi.org/10.1016/j.cej.2019.122822
  15. M. Xu, G. Yang, H. Bi, J. Xu, L. Feng et al., Combination of CuS and g-C3N4 QDs on upconversion nanops for targeted photothermal and photodynamic cancer therapy. Chem. Eng. J. 360, 866–878 (2019). https://doi.org/10.1016/j.cej.2018.12.052
  16. F. Du, H. Zhao, Y. Song, Z. Feng, K. Liu et al., Apoptosis-sensitizing tumor nanomedicine by regulating pyroptosis-associated inflammatory cell death. Adv. Funct. Mater. 34(44), 2406150 (2024). https://doi.org/10.1002/adfm.202406150
  17. L. Qiao, G. Zhu, T. Jiang, Y. Qian, Q. Sun et al., Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv. Mater. 36(8), 2308241 (2024). https://doi.org/10.1002/adma.202308241
  18. P. Tsvetkov, S. Coy, B. Petrova, M. Dreishpoon, A. Verma et al., Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375(6586), 1254–1261 (2022). https://doi.org/10.1126/science.abf0529
  19. L. Chen, J. Min, F. Wang, Copper homeostasis and cuproptosis in health and disease. Signal Transduct. Target. Ther. 7(1), 378 (2022). https://doi.org/10.1038/s41392-022-01229-y
  20. Y. Liu, R. Niu, H. Zhao, Y. Wang, S. Song et al., Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity. J. Am. Chem. Soc. 146(6), 3675–3688 (2024). https://doi.org/10.1021/jacs.3c08622
  21. L. Steffens, E. Pettinato, T.M. Steiner, A. Mall, S. König et al., High CO2 levels drive the TCA cycle backwards towards autotrophy. Nature 592(7856), 784–788 (2021). https://doi.org/10.1038/s41586-021-03456-9
  22. J. Zhu, Y. You, W. Zhang, W. Wang, M. Jiang et al., Sensitizing cuproptosis by endogenous copper-triggered bioorthogonal nanoremodeler. Nano Today 55, 102196 (2024). https://doi.org/10.1016/j.nantod.2024.102196
  23. I. Martínez-Reyes, N.S. Chandel, Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11(1), 102 (2020). https://doi.org/10.1038/s41467-019-13668-3
  24. V. Schulz, S. Basu, S.-A. Freibert, H. Webert, L. Boss et al., Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat. Chem. Biol. 19(2), 206–217 (2023). https://doi.org/10.1038/s41589-022-01159-4
  25. L. Sun, Y. Zhang, B. Yang, S. Sun, P. Zhang et al., Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023). https://doi.org/10.1038/s41467-023-42025-8
  26. W. Shen, P. Pei, C. Zhang, J. Li, X. Han et al., A polymeric hydrogel to eliminate programmed death-ligand 1 for enhanced tumor radio-immunotherapy. ACS Nano 17(23), 23998–24011 (2023). https://doi.org/10.1021/acsnano.3c08875
  27. L. Chan, Y. Liu, M. Chen, Y. Su, J. Guo et al., Cuproptosis-driven enhancement of thermotherapy by sequentially response Cu2-xSe via copper chemical transition. Adv. Funct. Mater. 33(33), 2302054 (2023). https://doi.org/10.1002/adfm.202302054
  28. S. Li, Y. Yue, W. Wang, M. Han, X. Wan et al., Ultrasound-activated probiotics vesicles coating for titanium implant infections through bacterial cuproptosis-like death and immunoregulation. Adv. Mater. 36(44), 2405953 (2024). https://doi.org/10.1002/adma.202405953
  29. Y.-Y. Wang, S.-L. Li, X.-Y. Zhang, F.-L. Jiang, Q.-L. Guo et al., “Multi-in-one” yolk-shell structured nanoplatform inducing pyroptosis and antitumor immune response through cascade reactions. Small 20(30), 2400254 (2024). https://doi.org/10.1002/smll.202400254
  30. K. Chen, A. Zhou, X. Zhou, Y. Liu, Y. Xu et al., An intelligent cell-derived nanorobot bridges synergistic crosstalk between sonodynamic therapy and cuproptosis to promote cancer treatment. Nano Lett. 23(7), 3038–3047 (2023). https://doi.org/10.1021/acs.nanolett.3c00434
  31. Q.-X. Huang, J.-L. Liang, Q.-W. Chen, X.-K. Jin, M.-T. Niu et al., Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today 51, 101911 (2023). https://doi.org/10.1016/j.nantod.2023.101911
  32. J. Xie, Y. Yang, Y. Gao, J. He, Cuproptosis: mechanisms and links with cancers. Mol. Cancer 22(1), 46 (2023). https://doi.org/10.1186/s12943-023-01732-y
  33. X.-K. Jin, J.-L. Liang, S.-M. Zhang, Q.-X. Huang, S.-K. Zhang et al., Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal cancer. Mater. Today 68, 108–124 (2023). https://doi.org/10.1016/j.mattod.2023.06.024
  34. Y. Xu, S.-Y. Liu, L. Zeng, H. Ma, Y. Zhang et al., An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv. Mater. 34(43), 2204733 (2022). https://doi.org/10.1002/adma.202204733
  35. C. Chen, M. Vázquez-González, M.P. O’Hagan, Y. Ouyang, Z. Wang et al., Enzyme-loaded hemin/G-quadruplex-modified ZIF-90 metal–organic framework nanops: bioreactor nanozymes for the cascaded oxidation of N-hydroxy-l-arginine and sensing applications. Small 18(11), 2104420 (2022). https://doi.org/10.1002/smll.202104420
  36. L.-H. Fu, Y. Wan, C. Qi, J. He, C. Li et al., Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv. Mater. 33(7), e2006892 (2021). https://doi.org/10.1002/adma.202006892
  37. M. Liu, H. Yu, L. Chen, T. Zhao, M. Fang et al., Spatially asymmetric cascade nanocatalysts for enhanced chemodynamic therapy. Nano Res. 16(7), 9642–9650 (2023). https://doi.org/10.1007/s12274-023-5486-4
  38. M. Chang, Z. Hou, M. Wang, D. Wen, C. Li et al., Cu single atom nanozyme based high-efficiency mild photothermal therapy through cellular metabolic regulation. Angew. Chem. Int. Ed. 61(50), e202209245 (2022). https://doi.org/10.1002/anie.202209245
  39. M. Chang, Z. Hou, M. Wang, C. Yang, R. Wang et al., Single-atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy. Angew. Chem. Int. Ed. 60(23), 12971–12979 (2021). https://doi.org/10.1002/anie.202101924
  40. T. Jia, Z. Wang, Q. Sun, S. Dong, J. Xu et al., Intelligent Fe–Mn layered double hydroxides nanosheets anchored with upconversion nanops for oxygen-elevated synergetic therapy and bioimaging. Small 16(46), 2001343 (2020). https://doi.org/10.1002/smll.202001343
  41. L. Yang, S. Dong, S. Gai, D. Yang, H. Ding et al., Deep insight of design, mechanism, and cancer theranostic strategy of nanozymes. Nano-Micro Lett. 16(1), 28 (2023). https://doi.org/10.1007/s40820-023-01224-0
  42. T. Futazuka, R. Ishikawa, N. Shibata, Y. Ikuhara, Grain boundary structural transformation induced by co-segregation of aliovalent dopants. Nat. Commun. 13(1), 5299 (2022). https://doi.org/10.1038/s41467-022-32935-4
  43. Y. Du, X. Zhao, F. He, H. Gong, J. Yang et al., A vacancy-engineering ferroelectric nanomedicine for cuproptosis/apoptosis co-activated immunotherapy. Adv. Mater. 36(30), e2403253 (2024). https://doi.org/10.1002/adma.202403253
  44. J. Qu, Y. Ge, B. Zu, Y. Li, X. Dou, Transition-metal-doped p-type ZnO nanop-based sensory array for instant discrimination of explosive vapors. Small 12(10), 1369–1377 (2016). https://doi.org/10.1002/smll.201503131
  45. X. Wei, Z. Li, H. Jang, M.G. Kim, S. Liu et al., Switching product selectivity in CO2 electroreduction via Cu−S bond length variation. Angew. Chem. Int. Ed. 63(39), e202409206 (2024). https://doi.org/10.1002/anie.202409206
  46. F. Alonso-Valenteen, S. Mikhael, H. Wang, J. Sims, M. Taguiam et al., Systemic HER3 ligand-mimicking nanobiops enter the brain and reduce intracranial tumour growth. Nat. Nanotechnol. 20(5), 683–696 (2025). https://doi.org/10.1038/s41565-025-01867-7
  47. P. Zhang, Y. Zhang, X. Ding, W. Shen, M. Li et al., A multistage cooperative nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy. Adv. Mater. 32(46), 2000013 (2020). https://doi.org/10.1002/adma.202000013
  48. X. Zhang, Y. Zhang, X. Lv, P. Zhang, C. Xiao et al., DNA-free guanosine-based polymer nanoreactors with multienzyme activities for ferroptosis-apoptosis combined antitumor therapy. ACS Nano 18(49), 33531–33544 (2024). https://doi.org/10.1021/acsnano.4c11275
  49. K. Xiao, Y. Li, J. Luo, J.S. Lee, W. Xiao et al., The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanops. Biomaterials 32(13), 3435–3446 (2011). https://doi.org/10.1016/j.biomaterials.2011.01.021
  50. M. Du, C.-P. Li, M. Chen, Z.-W. Ge, X. Wang et al., Divergent kinetic and thermodynamic hydration of a porous Cu(II) coordination polymer with exclusive CO₂ sorption selectivity. J. Am. Chem. Soc. 136(31), 10906–10909 (2014). https://doi.org/10.1021/ja506357n
  51. X. Zhang, L. Cheng, Y. Lu, J. Tang, Q. Lv et al., A MXene-based bionic cascaded-enzyme nanoreactor for tumor phototherapy/enzyme dynamic therapy and hypoxia-activated chemotherapy. Nano-Micro Lett. 14(1), 22 (2021). https://doi.org/10.1007/s40820-021-00761-w
  52. S. Lei, J. Zhang, N.T. Blum, M. Li, D.Y. Zhang et al., In vivo three-dimensional multispectral photoacoustic imaging of dual enzyme-driven cyclic cascade reaction for tumor catalytic therapy. Nat. Commun. 13(1), 1298 (2022). https://doi.org/10.1038/s41467-022-29082-1
  53. L. Li, Z. Lin, X. Xu, W. Wang, H. Chen et al., A pH/GSH/glucose responsive nanozyme for tumor cascade amplified starvation and chemodynamic theranostics. ACS Appl. Mater. Interfaces 15(35), 41224–41236 (2023). https://doi.org/10.1021/acsami.3c05412
  54. S. Cao, X. Xu, Q. Liu, H. Zhu, J. Wang et al., Superlong cycle-life sodium-ion batteries supported by electrode/active material interaction and heteroatom doping: Mechanism and application. J. Colloid Interface Sci. 674, 49–66 (2024). https://doi.org/10.1016/j.jcis.2024.06.145
  55. Y. Huang, B. Zhang, J. Li, Z. Zhou, S. Zheng et al., Unconventional doping effect leads to ultrahigh average thermoelectric power factor in Cu3SbSe4-based composites. Adv. Mater. 34(14), 2109952 (2022). https://doi.org/10.1002/adma.202109952
  56. S. Roychowdhury, T. Ghosh, R. Arora, U.V. Waghmare, K. Biswas, Stabilizing n-type cubic GeSe by entropy-driven alloying of AgBiSe2: ultralow thermal conductivity and promising thermoelectric performance. Angew. Chem. Int. Ed. 57(46), 15167–15171 (2018). https://doi.org/10.1002/anie.201809841
  57. S. Wang, Y. Qiao, X. Liu, S. Zhu, Y. Zheng et al., Reduced graphene oxides modified Bi2Te3 nanosheets for rapid photo-thermoelectric catalytic therapy of bacteria-infected wounds. Adv. Funct. Mater. 33(3), 2210098 (2023). https://doi.org/10.1002/adfm.202210098
  58. T. Jia, J. Du, J. Yang, Y. Li, T.Y. Ohulchanskyy et al., Metalloporphyrin MOFs-based nanoagent enabling tumor microenvironment responsive sonodynamic therapy of intracranial glioma signaled by NIR-IIb luminescence imaging. Adv. Funct. Mater. 34(3), 2307816 (2024). https://doi.org/10.1002/adfm.202307816
  59. Y. Jiang, X. Zhao, J. Huang, J. Li, P.K. Upputuri et al., Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy. Nat. Commun. 11(1), 1857 (2020). https://doi.org/10.1038/s41467-020-15730-x
  60. T. Liu, W. Liu, M. Zhang, W. Yu, F. Gao et al., Ferrous-supply-regeneration nanoengineering for cancer-cell-specific ferroptosis in combination with imaging-guided photodynamic therapy. ACS Nano 12(12), 12181–12192 (2018). https://doi.org/10.1021/acsnano.8b05860
  61. A. Sheikh, P. Kesharwani, W.H. Almalki, S.S. Almujri, L. Dai et al., Understanding the novel approach of nanoferroptosis for cancer therapy. Nano-Micro Lett. 16(1), 188 (2024). https://doi.org/10.1007/s40820-024-01399-0
  62. Y. Li, J. Liu, Y. Chen, R.R. Weichselbaum, W. Lin, Nanops synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv. Sci. 11(23), e2310309 (2024). https://doi.org/10.1002/advs.202310309
  63. S. Lu, Y. Li, Y. Yu, Glutathione-scavenging celastrol-Cu nanops induce self-amplified cuproptosis for augmented cancer immunotherapy. Adv. Mater. 36(35), 2404971 (2024). https://doi.org/10.1002/adma.202404971
  64. L. Wu, H. Lin, X. Cao, Q. Tong, F. Yang et al., Bioorthogonal Cu single-atom nanozyme for synergistic nanocatalytic therapy, photothermal therapy, cuproptosis and immunotherapy. Angew. Chem. Int. Ed. 63(27), e202405937 (2024). https://doi.org/10.1002/anie.202405937
  65. L. Xie, J. Li, G. Wang, W. Sang, M. Xu et al., Phototheranostic metal-phenolic networks with antiexosomal PD-L1 enhanced ferroptosis for synergistic immunotherapy. J. Am. Chem. Soc. 144(2), 787–797 (2022). https://doi.org/10.1021/jacs.1c09753
  66. Y.-B. Liu, X.-Y. Chen, B.-X. Yu, Y. Cen, C.-Y. Huang et al., Chimeric peptide-engineered self-delivery nanomedicine for photodynamic-triggered breast cancer immunotherapy by macrophage polarization. Small 20(22), 2309994 (2024). https://doi.org/10.1002/smll.202309994
  67. X. Hu, M. Zhang, C. Quan, S. Ren, W. Chen et al., ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics. Bioact. Mater. 36, 490–507 (2024). https://doi.org/10.1016/j.bioactmat.2024.06.038
  68. Z. Huang, J. Song, S. Huang, S. Wang, C. Shen et al., Phase and defect engineering of MoSe2 nanosheets for enhanced NIR-II photothermal immunotherapy. Nano Lett. 24(25), 7764–7773 (2024). https://doi.org/10.1021/acs.nanolett.4c01879
  69. A. Sarkar, V. Novohradsky, M. Maji, T. Babu, L. Markova et al., Multitargeting prodrugs that release oxaliplatin, doxorubicin and gemcitabine are potent inhibitors of tumor growth and effective inducers of immunogenic cell death. Angew. Chem. Int. Ed. 62(42), e202310774 (2023). https://doi.org/10.1002/anie.202310774
  70. M. Xu, R. Zhao, B. Liu, F. Geng, X. Wu et al., Ultrasmall copper-based nanoplatforms for NIR-II light-triggered photothermal/photodynamic and amplified nanozyme catalytic therapy of hypoxic tumor. Chem. Eng. J. 491, 151776 (2024). https://doi.org/10.1016/j.cej.2024.151776
  71. Q. Bai, M. Wang, J. Liu, X. Sun, P. Yang et al., Porous molybdenum nitride nanosphere as carrier-free and efficient nitric oxide donor for synergistic nitric oxide and chemo/sonodynamic therapy. ACS Nano 17(20), 20098–20111 (2023). https://doi.org/10.1021/acsnano.3c05790
  72. M. Wang, F. Xue, L. An, D. Wu, S. Sha et al., Photoacoustic-imaging-guided photothermal regulation of calcium influx for enhanced immunogenic cell death. Adv. Funct. Mater. 34(19), 2311853 (2024). https://doi.org/10.1002/adfm.202311853
  73. M. Zhang, X. Jin, M. Gao, Y. Zhang, B.Z. Tang, A self-reporting fluorescent salicylaldehyde–chlorambucil conjugate as a type-II ICD inducer for cancer vaccines. Adv. Mater. 34(36), 2205701 (2022). https://doi.org/10.1002/adma.202205701
Read More
Author biographies are not available.
Download this PDF file
PDF SUPPLEMENTARY FILE
Statistic
Read Counter : 460 Download : 347

Most read articles by the same author(s)

<< < 1 2